National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/7/2022 release of VAERS data:

Found 21,745 cases where Vaccine targets COVID-19 (COVID19) and Patient Died

Government Disclaimer on use of this data



Case Details

This is page 1266 out of 2,175

Result pages: prev   1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275   next


VAERS ID: 1235260 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2013-09-01
Onset:2021-03-11
   Days after vaccination:2748
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Magnetic resonance imaging, Myelopathy, Quadriplegia, Spinal cord compression, Spinal epidural haemorrhage, Spinal meningeal cyst
SMQs:, Peripheral neuropathy (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Guillain-Barre syndrome (broad), Accidents and injuries (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: MOVICOLON; PANTOPRAZOL [PANTOPRAZOLE]; FERROUS FUMARATE; MADOPAR; METOPROLOL SUCCINATE; ATORVASTATINE [ATORVASTATIN]; LEVODOPA/CARBIDOPA; APROVEL; RIVAROXABAN; CLOPIDOGREL
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Atrial fibrillation; Non STEMI
Allergies:
Diagnostic Lab Data: Test Name: MRI; Result Unstructured Data: Test Result:meningeal cyst at the level of vertebrae C5 and C6; Comments: Conclusion: meningeal cyst at the level of vertebrae C5 and C6 right dorsolateral with myelum compression and myelopathy herd over vertebrae C4-C7 (during surgery they found it was due to haemorrhage)
CDC Split Type: NLPFIZER INC2021399184

Write-up: epidural bleeding at C4-C6 with spinal cord injury/quadriplegia; epidural bleeding at C4-C6 with spinal cord injury; meningeal cyst at the level of vertebrae C5 and C6 right dorsolateral; myelum compression; myelopathy herd over vertebrae C4-C7; This is a spontaneous report from a contactable physician downloaded from the regulatory authority Regulatory Authority number NL-LRB-00493370. An 81-year-old male patient received the first dose of bnt162b2 (COMIRNATY), via an unspecified route of administration on 06Mar2021 (Batch/Lot Number: Unknown) as single dose for covid-19 immunisation; rivaroxaban, via an unspecified route of administration from Sep2013 (Batch/Lot Number: Unknown) to 12Mar2021, at 15 mg, once daily for atrial fibrillation; and clopidogrel, via an unspecified route of administration from Jun2020 (Batch/Lot Number: Unknown) to 12Mar2021, at 75 mg, once daily for non STEMI. Medical history included non STEMI and atrial fibrillation. The patient has no previous COVID-19 infection. Concomitant medications included macrogol, potassium chloride, sodium bicarbonate, sodium chloride (MOVICOLON), pantoprazol [pantoprazole], ferrous fumarate, benserazide hydrochloride, levodopa (MADOPAR), metoprolol succinate, atorvastatine [atorvastatin], carbidopa, levodopa (LEVODOPA/CARBIDOPA) and irbesartan (APROVEL). The patient experienced epidural bleeding at c4-c6 with spinal cord injury on 11Mar2021. The events were assessed as medically significant and require hospitalization. The patient had spinal epidural bleeding and quadriplegia following administration of Pfizer covid-19 vaccine. Spinal epidural bleeding and quadriplegia are treated with hospital admission and operation which had no effect. The spinal epidural bleeding was at C4-C6 and led to spinal cord injury: quadriplegia. The operation was not effective, and patient died 3 weeks later. Latency of events spinal epidural bleeding and quadriplegia was 5 days after of Pfizer Covid-19 vaccine, within 8 years after start of rivaroxaban tablet 15 mg and within 9 months after start of clopidogrel tablet 75mg. MRI showed a meningeal cyst at the level of vertebrae C5 and C6 right dorsolateral with myelum compression and myelopathy herd over vertebrae C4-C7 (during surgery they found it was due to haemorrhage). The action taken in response to the events for rivaroxaban and clopidogrel was permanently withdrawn on 12Mar2021. The outcome of the events "meningeal cyst at the level of vertebrae C5 and C6 right dorsolateral", "myelum compression" and "myelopathy herd over vertebrae C4-C7" were unknown. The patient died on an unspecified date due to epidural bleeding at C4-C6 with spinal cord injury/quadriplegia. It was unknown if an autopsy was performed. Reporter Comment: BioNTech / Pfizer vaccine (Comirnaty). Past drug therapy BioNTech / Pfizer vaccine (Comirnaty): no. Epidural haemorrhage at C4-C6 with spinal cord injury. Information council other or disabling information: deterioration in general condition with completely dependent and bedbound. High aspiration risk. Hospitalization information: Spinal cord injury and surgery,. Additional information ADR: Admission and operation in hospital, no improvement on spinal cord injury. Death 3 weeks later. BSN available: yes. COVID19 Previous COVID-19 infection: No. Other diagnostic procedures: MRI - Conclusion: Meningeal cyst at the level of vertebral body C5 and C6 right dorsolateral with myelum compression and myelopathy over a longer range of vertebral body C4-C7. (appears to be due to bleeding during surgery). No follow-up attempts are possible. Information about lot/batch number cannot be obtained.; Reporter''s Comments: Summary of Reporter Comment: Information council other or disabling information: deterioration in general condition with completely dependent and bedbound. High aspiration risk. Admission and operation in hospital, no improvement on spinal cord injury. Death 3 weeks later. MRI - Conclusion: Meningeal cyst at the level of vertebral body C5 and C6 right dorsolateral with myelum compression and myelopathy over a longer range of vertebral body C4-C7. (appears to be due to bleeding during surgery).; Reported Cause(s) of Death: epidural bleeding at C4-C6 with spinal cord injury/quadriplegia; epidural bleeding at C4-C6 with spinal cord injury


VAERS ID: 1235263 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-05
Onset:2021-02-08
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Abdominal pain, Epistaxis, Malaise
SMQs:, Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Retroperitoneal fibrosis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: PANTOPRAZOLE; NITRAZEPAM; NORTRIPTYLINE; CALCIUM + D3 [CALCIUM CARBONATE;CHOLECALCIFEROL]; BUSPIRONUM; IBANDRONINEZUUR ACTAVIS
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Inguinal hernia repair; Suspected COVID-19
Allergies:
Diagnostic Lab Data:
CDC Split Type: NLPFIZER INC2021398902

Write-up: nosebleed; Malaise; Abdominal pain; This is a spontaneous report from a contactable physician downloaded from a regulatory authority-WEB manufacturer report number NL-LRB-00501806. A 93-year-old female patient received bnt162b2 (COMIRNATY), via an unspecified route of administration on 05Feb2021, single dose for covid-19 immunisation. Medical history included suspected covid-19 from 08Feb2021, inguinal hernia repair from Feb2021 to an unknown date. Concomitant medications included pantoprazolum; nitrazepam; nortriptyline; calcium carbonate, colecalciferol (CALCIUM + D3); buspironum; ibandronate sodium (IBANDRONINEZUUR ACTAVIS). The patient experienced nosebleed, malaise, abdominal pain, all on 08Feb2021, all outcome was fatal. The patient died on an unspecified date. It was not reported if an autopsy was performed. No follow-up attempts possible. No further information expected; Reported Cause(s) of Death: nosebleed; Malaise; Abdominal pain


VAERS ID: 1235264 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-12
Onset:2021-03-16
   Days after vaccination:32
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Fatigue, Malaise, Nausea
SMQs:, Acute pancreatitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: NLPFIZER INC2021409108

Write-up: Fatigue; Nausea; Not feeling well; This is a spontaneous report from a contactable consumer downloaded from a regulatory authority-WEB, regulatory authority number NL-LRB-00502722. An 87-year-old female patient received bnt162b2 (COMIRNATY, Solution for injection), dose 1 via an unspecified route of administration on 12Feb2021 (Batch/Lot Number: Unknown) as single dose for covid-19 immunisation. The patient''s medical history and concomitant medications were not reported. On 16Mar2021, the patient experienced fatigue (death), nausea (death) and not feeling well (death). The patient died on an unspecified date in 2021. It was unknown if an autopsy was performed. No Past drug therapy Comirnaty. "BSN" was available. No Previous COVID-19 infection and no Other diagnostic procedures. The outcome of the events was fatal. Information about lot/batch number cannot be obtained. No further information is expected. ; Reported Cause(s) of Death: fatigue; nausea; not feeling well


VAERS ID: 1235265 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-06
Onset:2021-04-07
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Electrocardiogram, Laboratory test, Myocardial infarction
SMQs:, Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-01
   Days after onset: 6
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ACTRAPID; ATORVASTATIN; METOPROLOL
Current Illness: Coronary disease
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: ECG; Result Unstructured Data: Test Result:unknown results; Test Name: lab; Result Unstructured Data: Test Result:unknown results
CDC Split Type: NLPFIZER INC2021409162

Write-up: Myocardial infarction; This is a spontaneous report from a contactable physician downloaded from the regulatory authority, regulatory authority number NL-LRB-00502948. A 74-year-old male patient received the first dose of BNT162B2 (COMIRNATY), intramuscularly on 06Apr2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. Medical history included ongoing Coronary disease. Concomitant medications included insulin (ACTRAPID), atorvastatin and metoprolol. The patient experienced myocardial infarction on 07Apr2021. The event was reported as serious with serious criteria death. The patient underwent lab tests and procedures which included electrocardiogram (ECG): unknown results on unknown date, laboratory test: unknown results on unknown date. Therapeutic measures were taken as a result of myocardial infarction included treated with medications according to a protocol. The patient died on Apr2021. It was not reported if an autopsy was performed. Reporter''s Comments: BioNTech / Pfizer vaccine (Comirnaty), Past drug therapy BioNTech / Pfizer vaccine (Comirnaty): no. BSN available: yes. Confounding factors: Coronary suffering. Previous COVID-19 infection: No. Other diagnostic procedures: ECG, lab. No follow-up attempts are possible, information on batch number cannot be obtained.; Reporter''s Comments: BioNTech / Pfizer vaccine (Comirnaty), Past drug therapy BioNTech / Pfizer vaccine (Comirnaty): no. BSN available: yes. Confounding factors: Coronary suffering. Previous COVID-19 infection: No. Other diagnostic procedures: ECG, lab.; Reported Cause(s) of Death: Myocardial infarction


VAERS ID: 1235266 (history)  
Form: Version 2.0  
Age: 83.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-04-02
Onset:2021-04-02
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ET3674 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Arthralgia, Ecchymosis, Fatigue, Headache, Magnetic resonance imaging, Magnetic resonance imaging head, Malaise, Myalgia, Nausea, Pneumonia, Ventilation/perfusion scan
SMQs:, Rhabdomyolysis/myopathy (broad), Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Eosinophilic pneumonia (broad), Arthritis (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-04-01
   Days after onset: 1
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: OXAZEPAM; COTRIMOXAZOL; ACENOCOUMAROL
Current Illness: Bladder infection; Cardiac failure
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: MRI scan abdomen; Result Unstructured Data: Test Result:full or faeces; Test Name: MRI head; Result Unstructured Data: Test Result:MRI because of suspected meningitis: negative; Test Name: lung scan; Result Unstructured Data: Test Result:Pneumonia
CDC Split Type: NLPFIZER INC2021409178

Write-up: pneumonia, which was fatal; extensive hematomas; Headache; Pain in the joints; Fatigue; Nausea; Not feeling well, became deathly ill; Muscle pain; This is a spontaneous report from a contactable other HCP downloaded from a regulatory authority-WEB manufacturer report number NL-LRB-00503249. This is the first case of two reports for the second dose. An 83-year-old female patient received bnt162b2 (COMIRNATY), dose 2 via an unspecified route of administration on 02Apr2021 (Lot Number: ET3674) at age of 83 years old as single dose for covid-19 immunisation. Medical history included ongoing cardiac failure, ongoing bladder infection. Concomitant medications included oxazepam; sulfamethoxazole, trimethoprim (COTRIMOXAZOL); acenocoumarol. The patient previously took bnt162b2 (COMIRNATY), dose 1 via an unspecified route of administration on 25Feb2021 at single dose for covid-19 immunisation and experienced malaise, sudden deafness, and nausea. On 02Apr2021, the patient experienced malaise, myalgia, fatigue, nausea, pneumonia, generalized joint pain. On 03Apr2021, the patient experienced headache. On an unknown date, the patient experienced ecchymosis. All events were fatal and life threatening. Nausea was treated with acetylcysteine (FLUIMICIL). The outcome of all events was fatal. The patient died in Apr2021. It was not reported if an autopsy was performed. Reporter''s Comments: BioNTech / Pfizer vaccine (Comirnaty) Past drug therapy BioNTech / Pfizer vaccine (Comirnaty): yes ADRs: Nausea and sudden deafness, and just not feeling well Date: 25Feb2021. Incredible deafness after first Pfizer vaccine. Additional information ADR: Mothers has become critically ill. Her complaints were only heart failure, but for the rest still up to date. Already a deterioration in hearing after the first vaccination. Last week cystitis, she asked the doctor if she could have a vaccination. No problem. Admitted to hospital with pneumonia on Saturday 03April which was fatal. Thanks vaccination. COVID-19 Previous COVID-19 infection: No. Other diagnostic procedures: MRI scan abdomen - full of faeces - MRI head due to meningitis (was not) - Lung photo - Pneumonia. No follow-up attempts are possible. No further information is expected.; Reporter''s Comments: BioNTech / Pfizer vaccine (Comirnaty) Past drug therapy BioNTech / Pfizer vaccine (Comirnaty): yes ADRs: Nausea and sudden deafness, and just not feeling well Date: 25Feb2021 Incredible deafness after first Pfizer vaccine ; Sender''s Comments: Linked Report(s) : NL-PFIZER INC-2021415031 same patient, different vaccine dose and events; Reported Cause(s) of Death: Malaise; myalgia; ecchymosis; fatigue; nausea; generalized joint pain; headache; pneumonia


VAERS ID: 1235268 (history)  
Form: Version 2.0  
Age: 77.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-12
Onset:2021-04-12
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Syncope
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-12
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: NLPFIZER INC2021403560

Write-up: Collapsed and was reanimated/Man died shortly after administration Pfizer vaccine; This is a spontaneous report from a non-contactable consumer. A 77-years-old male patient received bnt162b2 (COMIRNATY, Batch/Lot number was not reported), via an unspecified route of administration on 12Apr2021 (at 77-years-old) as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. After the vaccination the patient waited for 15 minutes under supervision, before he went outside. Outside the patient collapsed and was reanimated before the emergency services came, the man was brought to the hospital by ambulance and died shortly after administration of Pfizer vaccine on the same day in the hospital on 12Apr2021. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Collapsed and was reanimated/Man died shortly after administration Pfizer vaccine


VAERS ID: 1235283 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-02-12
Onset:2021-02-01
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL8723 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: Body temperature, COVID-19, Cough, Fatigue, Laboratory test, Malaise, Pneumonia viral, Pyrexia, Respiratory failure, SARS-CoV-2 antibody test
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Acute central respiratory depression (narrow), Guillain-Barre syndrome (broad), Hypersensitivity (broad), Respiratory failure (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow), Hypokalaemia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-16
   Days after onset: 42
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Heart attack
Allergies:
Diagnostic Lab Data: Test Date: 202102; Test Name: temperture; Result Unstructured Data: Test Result:maintained; Comments: maintained until 20Feb2021; Test Date: 20210215; Test Name: temperture; Result Unstructured Data: Test Result:fever; Test Date: 202102; Test Name: tests; Result Unstructured Data: Test Result:done (unspecified results); Test Date: 202102; Test Name: COVID-19 test; Result Unstructured Data: Test Result:positive
CDC Split Type: PLPFIZER INC2021399736

Write-up: cough/choking cough; fever; very tiring; felt unwell/ill; pneumonia caused by a virus; severe respiratory failure; Covid-19; This is a spontaneous report from a contactable consumer. A 69-year-old male patient received bnt162b2 (COMIRNATY), dose 1 via an unspecified route of administration on 12Feb2021 (Lot Number: EL8723) as a single dose for covid-19 immunisation. Medical history included heart attack from 16Nov2020 to an unknown date. The patient''s concomitant medications were not reported. The reporter mentioned that her husband was vaccinated with the Pfizer Comirnaty vaccine and after the vaccination, he felt unwell sometime later, tests were done (unspecified results) on Feb2021, it turned out that the patient was ill, he has Covid. On 20Mar2021 (also reported as 16Mar2021), he was taken to hospital but unfortunately the patient died. The reporter confirmed that her husband had received the 1st dose of 12Feb21, lot number EL8723. From the third day (15Feb2021) after vaccination, a fever developed, and the patient was taking Teraflu. The temperature was maintained until 20Feb2021. Meanwhile a cough appeared. 25Feb2021, the cough worsened and the patient was referred for a COVID-19 test. The test came out positive on Feb2021. On 26Feb2021, the patient was in an ambulance but did not take him to the hospital. On 29Feb2021, the cough got worse and was very tiring. 01Mar2021 the patient was taken to hospital because of a choking cough. On 03Mar2021, the patient was connected to a respirator and on 16Mar2021, the patient died. The patient was not autopsied. Doctors cited COVID-19 as the cause of death, viral pneumonia and severe respiratory failure. The reporter mentioned that the patient on 16Nov2020 had a heart attack. He has been taking heart medications since then, but she has not stated what. The patient did not suffer from chronic diseases. The patient underwent lab tests and procedures which included COVID-19 test was positive on Feb2021, tests was done (unspecified results) on Feb2021 temperature was maintained until 20Feb2021 (Feb2021). The outcome of the events malaise and fatigue were unknown while the outcome of the other events was fatal. The patient died on 16Mar2021. An autopsy was not performed.; Reported Cause(s) of Death: pneumonia caused by a virus; severe respiratory failure; COVID-19


VAERS ID: 1235288 (history)  
Form: Version 2.0  
Age: 79.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-02-04
Onset:2021-02-06
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6136 / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Atrial fibrillation, Atrial flutter, Cerebral haemorrhage, Ischaemic stroke
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Supraventricular tachyarrhythmias (narrow), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, arterial (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-09
   Days after onset: 3
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Atherosclerosis; Cardiac insufficiency; Chronic renal failure; Diabetes; Hypertension; Persistent atrial fibrillation
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: PLPFIZER INC2021409070

Write-up: ischemic stroke of the brain with secondary haemorrhage; atrial fibrillation and flutter; atrial fibrillation and flutter; Ischemic stroke of the brain; This is a spontaneous report from a contactable consumer (patient''s granddaughter) downloaded from the regulatory authority [PL-URPL-DML-MLP.4401.2.127.2021]. A 79-year-old male patient received BNT162B2 (COMIRNATY, Lot Number: EJ6136) intramuscular on 04Feb2021 at age of 79-year-old at single dose for COVID-19 immunisation. Medical history included ongoing atherosclerosis, ongoing hypertension, ongoing diabetes, ongoing persistent atrial fibrillation, ongoing cardiac insufficiency (heart failure), ongoing chronic renal failure. The patient''s concomitant medications were not reported. The patient experienced ischemic stroke on 06Feb2021. The patient died on 09Feb2021. An autopsy was not performed. Direct cause of death: ischemic stroke of the brain with secondary haemorrhage; initial cause of death: atrial fibrillation and flutter. The outcome of the events was fatal. The reporting person did not classify the severity of the report. Due to the nature of the side effects and the patient''s death, HA classified the report as serious. Sender Comment: The reported adverse reactions have not yet been included under these terms in the Summary of Product Characteristics of Comirnaty. It cannot be ruled out that the reported cardiovascular diseases of the patient contributed to his death. HA has no information on any additional circumstances (medications used, allergies, etc.) that could have resulted in death. The temporal relationship supports a cause-and-effect relationship. The reporting person did not classify the severity of the report. Due to the nature of the side effects and the patient''s death, regulatory authority classified the report as serious. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: ischemic stroke of the brain with secondary haemorrhage; ischemic stroke of the brain with secondary haemorrhage; Atrial fibrillation and flutter; Atrial fibrillation and flutter


VAERS ID: 1235295 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-25
Onset:2021-04-04
   Days after vaccination:10
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER9470 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Cough, Upper gastrointestinal haemorrhage
SMQs:, Anaphylactic reaction (broad), Haemorrhage terms (excl laboratory terms) (narrow), Gastrointestinal haemorrhage (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-04
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Cardiac insufficiency (heart failure); COPD; Gastric disorder (recent gastric complaints); Hypertension arterial (high blood pressure); Prostate cancer (metastatic (bone) prostate carcinoma)
Allergies:
Diagnostic Lab Data:
CDC Split Type: PTPFIZER INC2021409082

Write-up: Massive upper gastrointestinal bleeding; Acute cough; This is a spontaneous report from a contactable nurse downloaded from the regulatory authority-WEB, Regulatory Authority number: PT-INFARMED-B202104-262. A 85-year-old male patient received the first dose of bnt162b2 (COMIRNATY, 30 mcg/0.3 ml), intramuscular on 25Mar2021 (Lot Number: ER9470) as 0.3 mL, single for covid-19 immunisation. Medical history included Cardiac insufficiency (heart failure), Gastric disorder (recent gastric complaints), Hypertension arterial (high blood pressure), Prostate cancer (metastatic (bone) prostate carcinoma), COPD; all from an unknown date and unknown if ongoing. The patient''s concomitant medications were not reported. The patient experienced massive upper gastrointestinal bleeding and acute cough on 04Apr2021. The reporter described that the patient started, at home, a picture of an accessory cough, followed by massive upper gastrointestinal bleeding, with immediate death. The outcome of the events was fatal. The patient died on 04Apr2021. It was not reported if an autopsy was performed. Reporter comment: Other information-Patient with multipathologies: COPD, metastatic prostate carcinoma (bone), hypertension, HF and recent gastric complaints, vaccinated on 25Mar2021 at home, with the first dose of COMIRNATY vaccine, starts with cough followed by hemorrhage massive upper digestive tract, with immediate death. No follow-up attempts are possible. No further information is expected.; Reporter''s Comments: Other information-Patient with multipathologies: COPD, metastatic prostate carcinoma (bone), hypertension, HF and recent gastric complaints, vaccinated on 25Mar2021 at home, with the first dose of COMIRNATY vaccine, starts with cough followed by hemorrhage massive upper digestive tract, with immediate death.; Reported Cause(s) of Death: Acute cough; massive upper gastrointestinal bleeding


VAERS ID: 1235308 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-01
Onset:2021-04-05
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW2239 / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Acute myocardial infarction
SMQs:, Myocardial infarction (narrow), Embolic and thrombotic events, arterial (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-07
   Days after onset: 2
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ENALAPRIL; PARACETAMOL; TATION; GABAPENTIN; MOMETASONE; TAMSULOSIN; FUROSEMIDE; CARVEDILOL; ALLOPURINOL; ASPIRINA; HYDROCORTISONE; PANTOPRAZOLE; BILAXTEN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Acute myocardial infarction (history of acute myocardial infarction); Arterial hypertension; Benign prostatic hypertrophy; Cataract; Chronic sinusitis; Dyslipidemia; Gout; Impotence; Ischemic heart disease; Knee osteoarthritis; Obesity; Varicose veins of lower extremities
Allergies:
Diagnostic Lab Data:
CDC Split Type: PTPFIZER INC2021409087

Write-up: Myocardial infarction acute; This is a spontaneous report from a contactable physician downloaded from the Medicines Agency (MA) -WEB, Regulatory Authority number: PT-INFARMED-V202104-666. An 86-year-old male patient received bnt162b2 (Pfizer vaccine, Solution for injection), dose 2 intramuscular on 01Apr2021 (Lot Number: EW2239) as 0.3 mL, single for covid-19 immunisation. Medical history included cataract, chronic sinusitis, knee osteoarthritis, benign prostatic hypertrophy, varicose veins of the leg, impotence, gout, arterial hypertension, obesity, history of acute myocardial infarction, ischemic heart disease without angina, dyslipidemia. Concomitant medication included enalapril; paracetamol; torasemide (TATION); gabapentin; mometasone; tamsulosin; furosemide; carvedilol; allopurinol; acetylsalicylic acid (ASPIRINA); hydrocortisone; pantoprazole; bilastine. The patient previously received the first dose of Pfizer vaccine on 04Mar2021 for covid-19 immunisation. The patient experienced myocardial infarction acute (death) on 05Apr2021. The patient died on 07Apr2021. An autopsy was not performed. It was reported that the patient had an acute myocardial infarction associated with the use of Pfizer vaccine, with a 2-dose vaccination schedule with an interval of 27 days between each dose. The adverse reaction (ADR) appeared 4 days after the administration, lasting 2 days, and the patient died. There was no suspicion of interaction between drugs. Specific treatment of the reaction in the Cardiology Intensive Care Unit (the specific treatment is unknown). Reporter said that according to the information consulted in the CSR, he thinks that an autopsy was not performed. Evolution ad ADR was Death. Relatedness of drug to reaction(s)/event(s): Pfizer vaccine / Myocardial infarction acute, Source of assessment was Reporter. Method of assessment was Unknown. Result of Assessment was Possible. The outcome of the event was fatal. No follow-up attempts possible. No further information is expected.; Reported Cause(s) of Death: Myocardial infarction acute


Result pages: prev   1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=1266&VAX=COVID19&VAXTYPES=COVID-19&DIED=Yes


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166